Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Mesa Laboratories Inc(MLAB)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for MLAB
09/23/2026: MLAB (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Mesa Laboratories is a specialized provider of quality validation and monitoring instruments for the life sciences and healthcare sectors. The company’s primary strength lies in its high-margin recurring revenue stream from consumables like biological indicators, which are essential for manufacturing compliance. Its core growth story centers on strategic 'buy-and-build' acquisitions that expand its footprint in specialized regulatory niches. However, risks include potential integration complexities, competitive pressure from larger life science providers, and reliance on evolving regulatory standards. Mesa may best suit growth-oriented investors who value a predictable, niche-focused business model, though they should carefully monitor future M&A execution and margin performance.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers moderate growth through M&A, though it lacks the explosive scaling typical of high-growth tech stocks. |
| Momentum investor | Weak fit | Momentum depends on specific market catalysts or positive earnings surprises that are not always present. |
| Value investor | Mixed fit | Valuation fluctuates based on the perceived quality of the company's niche market positioning and M&A integration success. |
| Dividend investor | Weak fit | Mesa is not primarily focused on high dividend yields, preferring to reinvest capital into growth. |
| Low-risk investor | Mixed fit | While the business model is inherently defensive, the small-cap nature of the stock can lead to higher volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | Smaller market capitalization leads to higher price swings relative to larger healthcare companies. |
| Valuation risk | Medium | Investors often pay a premium for high-quality recurring revenue models, creating valuation sensitivity. |
| Competition risk (specialized niches) | Medium | Larger players like STERIS or Fortive have greater resources to compete in specific product niches. |
| Business quality | Strong | The company provides essential, regulated products, ensuring stable, long-term demand. |
| Dividend income | Low / none | Dividends are a minor component of the total return strategy for this stock. |
| Execution risk | Medium / high | Success is highly dependent on identifying and integrating new acquisitions effectively. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -56.63% | Avg. Invested days 27 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/23/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 753.37M USD | Price to earnings Ratio 158.39 | 1Y Target Price 117.5 |
Price to earnings Ratio 158.39 | 1Y Target Price 117.5 | ||
Volume (30-day avg) 147.1K shares | Beta 0.96 | 52 Weeks Range 63.07 - 136.31 | Updated Date 09/23/2026 |
52 Weeks Range 63.07 - 136.31 | Updated Date 09/23/2026 | ||
Dividends yield (FY) 0.49% | Basic EPS (TTM) 0.85 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Sterilization/Validation Consumables | Biological and chemical indicators for healthcare and pharma sterilization verification. | This is the 'razor-and-blade' model, providing consistent recurring revenue from required compliance testing. |
| Calibration and Monitoring Equipment | Devices for monitoring temperature, pressure, and humidity in controlled industrial and lab environments. | These are capital equipment sales that serve as the foundation for ongoing monitoring needs. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 158.39 | Forward PE 34.48 | Enterprise Value 854.86M | Price to Sales(TTM) 3.02 |
Enterprise Value 854.86M | Price to Sales(TTM) 3.02 | ||
Enterprise Value to Revenue 3.42 | Enterprise Value to EBITDA 19.8 | Shares Outstanding 5.60M | Shares Floating 4.95M |
Shares Outstanding 5.60M | Shares Floating 4.95M | ||
Percent Insiders 5.62 | Percent Institutions 96.04 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Mesa Laboratories Inc
Exchange NASDAQ | Headquarters Lakewood, CO, United States | ||
IPO Launch date 1995-01-25 | CEO, President & Director Dr. Siddhartha Chandrakant Kadia B.E., M.S., Ph.D. | ||
Sector Technology | Industry Scientific & Technical Instruments | Full time employees 717 | Website https://www.mesalabs.com |
Full time employees 717 | Website https://www.mesalabs.com | ||
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.